Monoclonal antibodies are the building blocks of some of the most important medical treatments in the world. But they have limitations. For example, the large size of the molecules mean monoclonal ...
Tiny protein molecules derived from the blood of llamas and camels could be useful in treating brain disorders such as Alzheimer’s disease with fewer side effects, a new study says. These nanobodies ...
Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...
Nanobodies—tiny proteins derived from animals in the camelid family including camels, llamas, and alpacas—could be useful in treating brain disorders like schizophrenia and Alzheimer’s disease. In a ...
Lampreys are notorious for sucking blood, but they also produce antibody-like proteins with a taste for sugar. Dubbed lambodies, these proteins bind polysaccharides more tightly and specifically than ...
In the realm of immunodiagnostics, antibodies have long been invaluable tools, enabling the detection and measurement of various molecules with high specificity and sensitivity. Their significance in ...
LONDON (Reuters) - GlaxoSmithKline Plc's head of biotech research is excited about a new generation of "slimline" antibody medicines that may be successors to current blockbusters such as Avastin and ...
This article was originally featured in Knowable Magazine. Every four months, pathologist Aaron LeBeau scoops into a net one of the five nurse sharks he keeps in his University of Wisconsin lab. Then ...
Biology researchers have developed a new antibody therapy that can neutralize a wide variety of HIV-1 strains. They found success in an unlikely source -- llamas. A research team at Georgia State ...
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody ...
Tiny protein molecules derived from the blood of llamas and camels could be useful in treating brain disorders such as Alzheimer’s disease with fewer side effects, a new study says. These nanobodies ...